Day: November 4, 2025

Novo Nordisk submits updated proposal to acquire Metsera, Inc.

Written by Customer Service on November 4, 2025. Posted in Public Companies.

Bagsværd, Denmark, 4 November 2025 – On 30 October 2025, Novo Nordisk announced the submission of an unsolicited proposal to acquire Metsera, Inc. (Metsera)1. Today, Novo Nordisk confirms that it has submitted an updated, unsolicited proposal to acquire Metsera. The updated proposal has been declared superior by Metsera’s board of directors. The acquisition of Metsera, including its early and development-stage incretin and non-incretin analogue peptide programmes, would provide Novo Nordisk the opportunity to maximise the potential of Metsera’s complementary portfolio and capabilities. An acquisition would be in line with Novo Nordisk’s long-term strategy of developing innovative and differentiated medicines and treating millions more people living with obesity and diabetes and their associated comorbidities. About the updated proposal...

Davis Commodities Expands into the FMCG Market: A Bold Step Towards a Dynamic Future

Written by Customer Service on November 4, 2025. Posted in Public Companies.

SINGAPORE, Nov. 04, 2025 (GLOBE NEWSWIRE) — At Davis Commodities Limited, we have always believed in growth through innovation, adaptability, and vision. For decades, we’ve built a strong foundation as a trusted global trader of agricultural commodities, bringing essential products like sugar, rice, and oil to markets around the world. Today, we’re proud to announce an exciting new chapter in our journey: the expansion of our business into the Fast-Moving Consumer Goods (FMCG) market under our new entity: Davis Commodities SEA Pte. Ltd. Why FMCG & Why Now? The global FMCG industry is evolving faster than ever, driven by shifting consumer habits, growing middle-class markets, and the rise of digital commerce. As a company deeply rooted in the trade of everyday essentials, this expansion is a natural next step, allowing us...

Performance Shipping Inc. Secures Two-Year Time Charter Contract for M/T P. Long Beach at US$30,500 Per Day

Written by Customer Service on November 4, 2025. Posted in Public Companies.

ATHENS, Greece, Nov. 04, 2025 (GLOBE NEWSWIRE) — November 4, 2025 – Performance Shipping Inc. (NASDAQ: PSHG) (“we” or the “Company”), a global shipping company specializing in the ownership of tanker vessels, today announced that it has entered into a time charter contract with SeaRiver Maritime, a wholly owned subsidiary of ExxonMobil Corporation (“SeaRiver” or the “Charterer”), for its M/T P. Long Beach (the “vessel”), a 105,408 DWT LR2 Aframax tanker, built in 2013. Under the terms of the agreement, the vessel will be chartered for a period of 24 months, plus or minus 30 days at the Charterer’s option, at a daily gross charter rate of US$30,500. The vessel will be delivered to SeaRiver upon redelivery from her previous charterer, expected to be around mid-December 2025. This new charter increases the Company’s fleetwide secured...

Q3 2025: Financial guidance for 2025 narrowed

Written by Customer Service on November 4, 2025. Posted in Earnings Releases And Operating Results.

Announcement no. 13-2025 4 November 2025 Lasse Ingemann Brodt, Group CEO of North Media, on the Group’s performance in Q3 2025:“Our Q3 2025 performance reflected a slightly lower activity level. We saw slight revenue declines in both Last Mile and Digital Services. We generated operating profit growth in Digital Services, where we reduced the losses in Dayli and Bekey by completing development projects and enhancing the efficiency of key processes. In October, we reached an important milestone in the integration of SDR into North Media as the roll-out of automated packing of printed matter for the Swedish market has now been fully completed. This creates more uniform processes across the distribution areas in Sweden and is expected to lead to costs reductions in the long term. Financial highlights:DKKm Q3 Q3 YTD 2025 2024 2025 2024Revenue 286.4 299.4 939.2 961.4EBITDA 12.1 19.4 71.1 120.9EBIT -1.7 3.0 29.3 59.2EBIT...

Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights

Written by Customer Service on November 4, 2025. Posted in Earnings Releases And Operating Results.

– Data update from vopimetostat (TNG462) showed 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months– – Combination studies with RAS(ON) inhibitors ongoing, data anticipated 2026 – – 49% ORR and mPFS 9.1 months in histology selective cohort of multiple late line, difficult to treat cancers provide further evidence of strong activity – – $225 million in gross proceeds from October 2025 financing extends cash runway into 2028 – BOSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today reported financial results for the third quarter ended September 30, 2025, and provided business highlights. “We are wrapping up 2025 with significant momentum,...

MKS Inc. Declares Quarterly Cash Dividend

Written by Customer Service on November 4, 2025. Posted in Dividend Reports And Estimates.

ANDOVER, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) — MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, payable on December 5, 2025, to shareholders of record as of November 24, 2025. Future dividend declarations, as well as the record and payment dates for such dividends, are subject to the final determination of the Company’s Board of Directors. About MKS Inc.MKS Inc. (NASDAQ: MKSI) enables technologies that transform our world. We deliver foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. We apply our broad science and engineering capabilities to create instruments, subsystems, systems,...

LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform

Written by Customer Service on November 4, 2025. Posted in Public Companies.

Transaction Values WorkSimpli at $65 Million Enterprise Value; Supports LifeMD’s Strategic Focus on Scaling its Virtual Care and Pharmacy Businesses NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services and pharmacy, today announced the sale of its majority ownership interest in WorkSimpli Software LLC (“WorkSimpli”) in a transaction valuing WorkSimpli at an enterprise value of approximately $65 million. The buyer group was led by WorkSimpli founder and CEO Sean Fitzpatrick, with support from a private investment group. This transaction represents a key milestone in LifeMD’s strategic transformation, further positioning the Company as a pure-play healthcare company exclusively focused on expanding its virtual care and pharmacy offerings. Under the terms of the...

CytomX Therapeutics to Present CX-801 Phase 1 Monotherapy Biomarker Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Written by Customer Service on November 4, 2025. Posted in Public Companies.

– CX-801 (PROBODY® interferon alpha-2b) Phase 1 data demonstrate activation of tumor-selective interferon signaling in patients with advanced melanoma – – Data supportive of CX-801’s mechanism of action and the ongoing Phase 1 combination study with KEYTRUDA® (pembrolizumab) – SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that initial translational data from the ongoing Phase 1 study of CX-801 in patients with advanced melanoma will be presented at the Society for Immunotherapy of Cancer (SITC) 40th Anniversary Annual Meeting, being held in National Harbor, MD on November 7-9, 2025. “CX-801 was intentionally designed to unlock the powerful immune-modulating effects...

ECD Automotive Design’s Project Gravette Porsche Wins “Best in Show – European Modified” at the 2025 Festivals of Speed

Written by Customer Service on November 4, 2025. Posted in Public Companies.

The Fully Bespoke Porsche 993, Quickly Captured the Attention of Attendees and JudgesKISSIMMEE, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) — ECD Automotive Design, Inc. (“ECD” or the “Company”) (NASDAQ: ECDA), the world’s largest Land Rover and Jaguar restoration company known for its custom luxury builds, including bespoke Defenders, Range Rovers, Jaguar E-Types, Ford Mustangs and Toyota FJs, is proud to announce that its Project Gravette Porsche 993 earned Best in Show – European Modified Division at the 2025 Festivals of Speed, held October 26, 2025, at the Mission Resort + Club in Howey-in-the-Hills, Florida. The Project Gravette Porsche 993, ECD’s first Porsche 911 customization, made its pubic debut and quickly captured the attention of attendees and judges at the Festivals of Speed. “The Festivals of Speed is a premier showcase...

Fluent, Inc. to Announce Third Quarter 2025 Financial Results and Host Earnings Conference Call on November 13, 2025

Written by Customer Service on November 4, 2025. Posted in Public Companies.

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Fluent, Inc. (NASDAQ: FLNT) today announced that it will report financial results for the third quarter ended September 30, 2025, after the close of the U.S. financial markets on November 13, 2025. Fluent will host a conference call at 4:30 pm ET on the same day to discuss the results. The conference call can be accessed by phone after registering online at Fluent Conference Call or via audio at Audio Registration. The call and accompanying slide presentation will also be webcast simultaneously on the Fluent website on the Investor Relations Page. Please log in at least 15 minutes prior to the start of the call to ensure adequate time for any downloads that may be required. Following the call, a recorded replay of the webcast will be available for one year on Fluent’s Investor Relations...

Day: November 4, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals